CoChat

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

Background The introduction of second-generation antipsychotic drugs during the 1990s is widely believed to have adversely affected mortality of patients with schizophrenia. Our aim was to establish the long-term contribution of antipsychotic drugs to mortality in such patients.Methods Nationwide registers in Finland were used to compare the cause-specific mortality in 66 881 patients versus the total population (5.2 million) between 1996, and 2006, and to link these data with the use of antipsychotic drugs. We measured the all-cause mortality of patients with schizophrenia in outpatient care during current and cumulative exposure to any antipsychotic drug versus no use of these drugs, and exposure to the six most frequently used antipsychotic drugs compared with perphenazine use.Findings Although the proportional use of second-generation antipsychotic drugs rose from 13% to 64% during follow-up, the gap in life expectancy between patients with schizophrenia and the general population did not widen between 1996 (25 years), and 2006 (22.5 years). Compared with current use of perphenazine, the highest risk for overall mortality was recorded for quetiapine (adjusted hazard ratio [HR] 1.41, 95% CI 1.09-1.82), and the lowest risk for clozapine (0.74, 0.60-0.91; p=0.0045 for the difference between clozapine vs perphenazine, and p<0.0001 for all other antipsychotic drugs). Long-term cumulative exposure (7-11 years) to any antipsychotic treatment was associated with lower mortality than was no drug use (0.81, 0.77-0.84). In patients with one or more filled prescription for an antipsychotic drug, an inverse relation between mortality and duration of cumulative use was noted (HR for trend per exposure year 0.991; 0.985-0.997).Interpretation Long-term treatment with antipsychotic drugs is associated with lower mortality compared with no antipsychotic use. Second-generation drugs are a highly heterogeneous group, and clozapine seems to be associated with a substantially lower mortality than any other antipsychotics. Restrictions on the use of clozapine should be reassessed.Funding Annual EVO Financing (Special government subsidies from the Ministry of Health and Welfare, Finland).

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(09)60742-x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 32 references

Cited by

See all 1,354

Metadata

Authors
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J.
Affiliations
  • University of Helsinki (FI)
  • Vaasa Central Hospital (FI)
  • Social Insurance Institution (FI)
  • Kuopio University Hospital (FI)
Corresponding author
Tiihonen, Jari
Venue
The Lancet
Publisher
Elsevier BV
Published
2009-08
Volume
374
Issue
9690
Pages
620-627
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2113463828
Cited by
1,354
References
32
Citations by year
2026: 30 · 2025: 36 · 2024: 37 · 2023: 48 · 2022: 37 · 2021: 50 · 2020: 260 · 2019: 67 · 2018: 68 · 2017: 74 · 2016: 90 · 2015: 90 · 2014: 99 · 2013: 84 · 2012: 102
FWCI
58.34
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Funders
Kela
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Social Sciences › Psychology › Clinical Psychology › Historical Psychiatry and Medical Practices
  • Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords
schizophrenia, mortality, atypical antipsychotics, clozapine, quetiapine, perphenazine, life expectancy, cause-specific mortality, antipsychotic safety, long-term treatment outcomes, Finland
MeSH terms
Quetiapine Fumarate, Adult, Aged, Cause of Death, Clozapine, Dibenzothiazepines, Drug Utilization, Female, Finland, Follow-Up Studies, Humans, Life Expectancy, Male, Middle Aged, Patient Readmission, Perphenazine, Registries, Risk Factors, Schizophrenia, Time Factors, Antipsychotic Agents, Proportional Hazards Models, Case-Control Studies, Age Distribution, Sex Distribution, Health Status Disparities

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). https://app.cochat.ai/papers/10.1016/s0140-6736(09)60742-x
The paper
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., Klaukka, T., Niskanen, L., Tanskanen, A., & Haukka, J. (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). The Lancet. https://doi.org/10.1016/s0140-6736(09)60742-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.